Holdings
Pfizer Inc
As of Jun 30, 2026, Pfizer Inc reported 14 positions worth US$158M. Largest: Allogene Therapeutics, Inc., Celcuity Inc. and Arvinas, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 22M | US$46.9M | no change | Jun 30, 2026 |
| Celcuity Inc. | 296K | US$29.6M | no change | Jun 30, 2026 |
| Arvinas, Inc. | 3.46M | US$27.7M | no change | Jun 30, 2026 |
| Pyxis Oncology, Inc. | 7.03M | US$19.5M | no change | Jun 30, 2026 |
| Biohaven Ltd. | 506K | US$8M | no change | Jun 30, 2026 |
| Caribou Biosciences, Inc. | 4.69M | US$7.88M | no change | Jun 30, 2026 |
| Spero Therapeutics, Inc. | 2.36M | US$5.34M | no change | Jun 30, 2026 |
| Zentalis Pharmaceuticals, Inc. | 954K | US$3.85M | no change | Jun 30, 2026 |
| Oric Pharmaceuticals, Inc. | 373K | US$3.55M | −4.41M | Jun 30, 2026 |
| Cardiff Oncology, Inc. | 2.41M | US$3.01M | no change | Jun 30, 2026 |